Vitro Diagnostics (Aurora, Colorado), a biotechnology company developing the Vitrocell brand of human cell lines, reported the establishment of East Coast operations in central New Jersey. This facility will manage business development and fund-raising activities of the company while corporate headquarters, research & development and manufacturing operations will continue in Colorado.
Dr. James Posillico, Vitro's recently appointed president and CEO, said, "The new East Coast operation allows the company proximity to financial organizations and headquarters of various biotechnology and pharmaceutical firms that are potential collaborators. There are additional opportunities for collaboration and alliance establishment with firms located in eastern Canada and Europe. The opening of our new operations on the eastern seaboard facilitates our business development initiatives and capital raising efforts while we continue manufacturing and R&D activities without interruption in Colorado."